Close

NewLink Genetics (NLNK) Enters NLG919 Licensing and Collaboration Agreement with Roche

October 20, 2014 7:05 AM EDT Send to a Friend
NewLink Genetics Corporation (Nasdaq: NLNK) announced that they have entered into an exclusive worldwide license agreement with Genentech, a member ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login